- Home
- About ASF
- What is Autism?
- What We Fund
- Autism Science
- Media Center
- Get Involved
- Contact Us
Seaside Therapeutics Secures $30 Million Financing
Source:
Reuters
Date Published:
September 17, 2009
Abstract:
Seaside Therapeutics LLC today announced that it has secured $30 million in financing from a private, family investment firm which is committed to advancing research in the field of autism and Fragile X Syndrome.


